DNA repair gene polymorphisms and bladder cancer susceptibility in a Turkish population

Anticancer Research

Volumn 26, Issue 6 C, 2006, Pages 4955-4958

  Karahalil, Bensu ^a   Kocabas, Neslihan Aygün ^a   Özçelik, Tayfun ^b  

^a GAZI UNIVERSITY   (Turkey)

^b BILKENT UNIVERSITY   (Turkey)

Author keywords

Arg399Gln; Bladder cancer; Cigarette smoking; OGG; Polymorphism; Ser326Cys; Turkish population; XRCC1

Indexed keywords

ARGININE; CYSTEINE; GLUTAMINE; NUCLEAR PROTEIN; PROTEIN 8 OXOGUANINE DNA GLYCOSYLASE 1; PROTEIN X RAY REPAIR CROSS COMPLEMENTING 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CIGARETTE SMOKING; CONTROLLED STUDY; DNA POLYMORPHISM; DNA REPAIR; EXCISION REPAIR; GENE FREQUENCY; GENETIC ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TURKEY (REPUBLIC);

ADULT; AGED; AGED, 80 AND OVER; DNA GLYCOSYLASES; DNA REPAIR; DNA-BINDING PROTEINS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; TURKEY; URINARY BLADDER NEOPLASMS;

EID: 33845915564     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Greenlee RT, Murray T, Bolden S and Wingo PA: Cancer statistics, CA Cancer J Clin 50: 7-33, 2000.
2. Ozsari H and Atasever L: Cancer registry report of Turkey 1993-1994. Turkish Ministry of Health, pp. 5-6, 1997.
3. Beckman KB and Ames BN: Oxidative decay of DNA. J Biol Chem 272: 19633-19636, 1997.
4. Boiteux S and Radicella P: The human OGG1 gene: structure, functions, and its implication in the process of carcinogenesis. Arch Biochem Biophy 377: 1-8, 2000.
5. Wu X, Zhao H, Suk R and Christiani DC: Genetic susceptibility to tobacco-related cancer. Oncogene 23: 6500-6523, 2004.
6. Burch JD, Rohan TE, Howe GR, Risch HA, Hill GB, Steele R and Miller AB: Risk of bladder cancer by source and type of tobacco exposure: a case-control study. Int J Cancer 44: 622-628, 1989.
7. Taylor JA, Umbach DM, Stephens E, Castranio T, Paulson D, Robertson C, Mohler JL and Bell DA: The role of N-acetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene-gene exposure three-way interaction. Cancer Res 58: 3603-3610, 1998.
8. Smith TR, Miller MS, Lohman K, Lange EM, Case LD, Mohrenweiser HW and Hu JJ: Polymorphisms of XRCC1 and XRCC3 genes and susceptibility to breast cancer. Cancer Lett 190: 183-190, 2003.
9. Shen MR, Jones LM and Mohrenweise H: Non conservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res 58: 604-608, 1998.
10. Shibutani S, Takeshita M and Grollman AP: Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG. Nature 349: 431-434, 1991.
11. Nash RA, Caldecott KW, Barner DE and Lindahl T: XRCC1 protein interacts with one of two distinct forms of DNA ligase III. Biochem 36: 5207-5211, 1997.
12. Brem R and Hall J: XRCC1 is required for DNA single-strand break repair in human cells. Nucleic Acids Res 33: 2512-2520, 2005.
13. Kelsey KT, Park S, Nelson HH and Karagas MR: A population-based case-control study of the XRCC1 Arg399Gln polymorphism and susceptibility to bladder cancer. CEBP 13: 1337-1341, 2004.
14. Goode EL, Ulrich CM and Potter JD: Polymorphisms in DNA Repair Genes and Associations with Cancer Risk. CEBP 11: 1513-1530, 2002.
15. Takezaki T, Gao C, Wu J, Li Z, Wing JD, Ding J, Liu Y, Hu X, Xu T, Tajima K and Sugimura H: hOGG1 Ser326Cys polymorphism and modification by environmental factors of stomach cancer risk in Chinese. Int J Cancer 99: 624-627, 2002.
16. Kim JI, Park YJ, Kim KH, Kim JI, Song BI, Lee MS, Kim CN and Chang SH: hOGGI Ser326Cys polymorphism modifies the significance of the environmental risk factor for colon cancer. World J Gastroenterol 9: 956-960, 2003.
17. Törüner GA, Akyerli C, Uçar A, Aki T, Atsu N, Özen H, Tez M, Çetinkaya M and Ozcelik T: Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and bladder cancer susceptibility. Arch Toxicol 75: 459-464, 2001.
18. Karahalil B and Kocabas NA: hOGG1 ser326cys genetic polymorphism in a Turkish population. Arch Toxicol 79: 377-380, 2005.
19. Sturgis EM, Castillo EJ, Li L, Zheng R and Eicher SA, Clayman GL, Strom SS, Spitz MR and Wei Q: Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. Carcinogenesis 20: 2125-2129, 1999.
20. Stern MC, Umbach DM, Gils CH, Lunn RM and Taylor JA: DNA repair gene XRCC1 polymorphisms, smoking and bladder cancer risk. CEBP 10: 125-131, 2001.
21. Kocabas NA and Karahalil B: Genetic polymorphism in a Turkish population. Int J Toxicol 25: 419-422, 2006.
22. Kim EJ, Jeong P, Quan C, Kim J, Bae SC, Yoon SJ, Kang JW, Lee SC, Jun Wee J and Kim WJ: Genotypes of TNF-alpha, VEGF, hOGG1, GSTM1, and GSTT1: useful determinants for clinical outcome of bladder cancer. Urology 65: 70-75, 2005.
23. Shen M, Hung RJ, Brennan P, Malaveille C, Donato F, Placidi D, Carta A, Hautefeuille A, Boffetta P and Porru S: Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy. Cancer Epidemiol Biomarkers Prev 12: 1234-1240, 2003.